Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer
NCT ID: NCT05318131
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2022-08-30
2023-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia
NCT03444532
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
NCT02957357
Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
NCT03331458
Assessing Quality of Life of Patients With Prostate Cancer
NCT00041301
A Study of Cognitive Health in Survivors of Prostate Cancer
NCT05540782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm Prospective Study
Sleep and Lifestyle Advice Website
Participants will be asked to view a website at least once a week for 3 months (remotely). The website includes information about exercise, nutrition and sleep. Participants will also have a check-in call with a health coach at 6 weeks, and will be sent email newsletters at approximately 1 and 2 months with additional information about sleep, nutrition, and exercise.
Surveys and Sleep Monitors
At baseline and at 3 months, participants will be asked to complete online surveys and to wear an ActiGraph sleep monitor for one week. ActiGraph sleep monitors are wristbands that measure continuous sleep/wake activity information. The recorded ActiGraph data is deidentified and no individual personally identifiable information is collected. A unique serial number identifies each wrist monitor. At the end of the study, participants will also have a telephone exit interview with the study team to provide feedback on their progress during the study and about the website.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sleep and Lifestyle Advice Website
Participants will be asked to view a website at least once a week for 3 months (remotely). The website includes information about exercise, nutrition and sleep. Participants will also have a check-in call with a health coach at 6 weeks, and will be sent email newsletters at approximately 1 and 2 months with additional information about sleep, nutrition, and exercise.
Surveys and Sleep Monitors
At baseline and at 3 months, participants will be asked to complete online surveys and to wear an ActiGraph sleep monitor for one week. ActiGraph sleep monitors are wristbands that measure continuous sleep/wake activity information. The recorded ActiGraph data is deidentified and no individual personally identifiable information is collected. A unique serial number identifies each wrist monitor. At the end of the study, participants will also have a telephone exit interview with the study team to provide feedback on their progress during the study and about the website.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Adult U.S. male or female \>18 who is a family member/partner/caregiver of a prostate cancer patient AND
3. Telephone and internet access AND
4. Able to read, comprehend, and sign informed consent in English AND
5. Perceived deficits in sleep, nutrition, and/or physical activity
Exclusion Criteria
2. Not English proficient
3. No or irregular access to the same telephone number and/or mailing address
4. No or less than weekly access to the internet
5. Patients who do not have a diagnosis of prostate cancer
6. Caregivers/family members for a condition other than prostate cancer
7. Mental or cognitive impairment that interferes with ability to provide informed consent
8. Surgery within the past 6 weeks or planned within the next 3 months (must wait until cleared to participate)
9. Other restrictions or upcoming events that affect sleep, physical activity or nutrition (e.g. doctor's orders)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York State Department of Health
OTHER_GOV
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacy Loeb, MD MSc
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Loeb S, Robbins R, Sanchez-Nolasco T, Byrne N, Ruan A, Rivera A, Gupta N, Kenfield SA, Chan JM, Van Blarigan EL, Carter P, Jean-Louis G, Orstad SL. Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers. BJUI Compass. 2024 Aug 31;5(10):976-985. doi: 10.1002/bco2.435. eCollection 2024 Oct.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-00078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.